Image

Study of RYZ101 Compared with SOC in Pts W Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Comparing RYZ101 with standard care for certain advanced neuroendocrine tumors.

Recruiting
18 years and older
All
Phase 3

This study is for people with a type of cancer called GEP-NETs (gastroenteropancreatic neuroendocrine tumors), which have grown even after specific treatments. These tumors have special features called SSTR+ (somatostatin receptor expressing), making them hard to operate on. The study will test a new drug, RYZ101, to see if it's safe and works well compared to usual treatments. In the first part of the study, researchers will find the best dose of RYZ101. In the second part, they'll compare its effects with the standard care treatments.

  • Participation includes treatment with either RYZ101 or standard care.
  • The study requires meeting specific health criteria and having certain test results.
  • Participants cannot have certain conditions like heart problems or uncontrolled diabetes.

If you have questions or want more information, talk with your doctor to see if this study might be right for you.

Study details
    GEP-NET
    Gastroenteropancreatic Neuroendocrine Tumor
    Gastroenteropancreatic Neuroendocrine Tumor Disease
    Neuroendocrine Tumors
    Carcinoid
    Carcinoid Tumor
    Pancreatic NET

NCT05477576

RayzeBio, Inc.

2 February 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.